Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 18, 2017 | Series B | $23.10M | 2 | Boston Scientific | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boston Scientific | Yes | Series B |
Lord Baltimore Investment Partners | — | Series B |